Johnson & Johnson MedTech buys Laminar for USD 400 million Ruchika Sharma3 Dec 2023 12:30 PM ISTNew Brunswick: Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, Inc., a privately-held medical device...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
Johnson and Johnson faces 18 talc cancer trials, prompting it again to consider bankruptcy Roshni Dhar30 Oct 2023 2:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcy Ruchika Sharma27 Oct 2023 5:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
JnJ names Tim Schmid as Executive Vice President, Worldwide Chairman of MedTech Ruchika Sharma25 Oct 2023 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the...
First pill for dengue shows promise in human challenge trial Roshni Dhar23 Oct 2023 3:30 PM ISTA pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human...
First dengue pill shows promise in human challenge trial Ruchika Sharma21 Oct 2023 4:58 PM ISTNew Delhi: A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a...
JnJ embarks on two year restructuring program for orthopedics business Ruchika Sharma19 Oct 2023 12:25 PM ISTNew Jersy: Johnson & Johnson has said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter...
Indian Pharma cos get green signal to distribute generic Bedaquiline in low, middle income countries Ruchika Sharma3 Oct 2023 3:30 PM ISTNew Delhi: Indian pharmaceutical manufacturers have received a green light to distribute the generic anti-TB drug Bedaquiline to other countries...
JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
